MRI: prostate cancer
The Institute of Cancer Research at the Royal Marsden Hospital in Sutton received Wellcome Trust support to add a new MRI scanner to its Clinical Magnetic Resonance Research Group's imaging suite.
The Clinical Magnetic Resonance Research Group plays a key role in the joint institution.
Its research programme is directed towards:
- developing diagnostic and prognostic markers of tumour function and metabolism
- using advanced magnetic resonance techniques to improve disease staging.
This improves stratification of patients for management and entry into trials.
The Group has incorporated MRI into monitoring patients on an active surveillance programme for management of early prostate cancer.
The paper 'Combined Use of Diffusion-Weighted MRI and 1H MR Spectroscopy to Increase Accuracy in Prostate Cancer Detection' was published in the 'American Journal of Roentgenology' in 2007.
Find out more about The Institute of Cancer Research.
Image credit: Prostate cancer cells; Annie Cavanagh